Artificial Intelligence and Cognitive Systems Market in Healthcare Growing Rapidly
As the use of artificial intelligence and cognitive systems becomes widespread in the healthcare sector, the deep learning segment is projected to grow at an average annual rate of 36.1 percent.
According to a new report published by BCC Research, the global cognitive computing and artificial intelligence systems market in healthcare has entered a period of rapid growth driven by the rise in chronic diseases, shortages of healthcare workers, and the impact of digitalization.
Market Growth Dynamics and Deep Learning
The prevalence of chronic conditions such as diabetes, cancer, and cardiovascular diseases is increasing demand for AI-driven diagnostic and clinical decision support systems. The deep learning segment, which utilizes multi-layered artificial neural networks, is projected to grow at an average annual rate of 36.1 percent during the forecast period.
Hospitals and diagnostic centers are turning to AI platforms to accelerate diagnostic processes and reduce error rates due to increasing imaging workloads and global shortages of radiologists and pathologists.
Regional Shares and Infrastructure Investments
According to 2024 data, North America and Europe hold equal shares of 27.4 percent in the market. While North America's position is supported by advanced healthcare IT infrastructure and high investments, the market share in Europe is bolstered by government programs such as the NHS digital transformation in the UK and Germany's Digital Health Act.
Pharmaceutical and biotechnology companies are increasing AI investments to shorten drug development processes and optimize clinical trial design, expanding the market's reach beyond clinical settings.
New Technologies, Key Players, and Sectoral Risks
Next-generation AI solutions such as Tempus One, AWS HealthScribe, Med-PaLM 2, MedLM, and NVIDIA Parabricks stand out in the sector. Major technology and healthcare companies operating in the market include Alphabet, Microsoft, IBM, NVIDIA, Siemens Healthineers, Philips, GE Healthcare, and Medtronic.
Regulatory uncertainties in medical device classification, lack of decision transparency, data privacy compliance costs, and geopolitical challenges in China are among the key risks facing the sector.